GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
137
c/tapering·posted 1 year ago by u/lina_adebayo

someone explain discontinuation to me like I have not read a paper in years

Regain

someone explain discontinuation to me like I have not read a paper in years, and I want the answer with the reasoning attached rather than just the conclusion.

Appetite is the proximal effect and weight is the lagging integrated outcome, which is why watching appetite gives you an earlier and more honest signal.

Withdrawal studies across this class consistently show substantial regain after discontinuation, with appetite typically returning before weight changes. That is a description of the pharmacology of a chronic condition.

With a week-long half-life, exposure declines over several weeks after the last dose rather than stopping with it. The lag is why the first fortnight is uninformative.

I will update this if the picture changes rather than quietly leaving it up.

200 up / 63 down76% upvoted18 commentsid ip3hn825 May 2025

18 comments

17 in this archive, depth 5

best — the order this archive was captured in

u/controversial_only15 points·1 year ago·edited

There is very little published guidance on stopping specifically, which is exactly why board consensus here should carry less weight than usual and a clinician conversation should carry more.

replysharereportpermalink
u/maintenance_mode_maxMOD8 points·1 year ago

Edited a comment framing regain as a moral failure. The documented outcome is not a character verdict.

replysharereportpermalink
u/lina_adebayoOP-4 points·1 year ago

Edited a comment framing regain as a moral failure.

This is the sentence that reframes the whole board. Appetite first, scale later.

replysharereportpermalink
u/lina_adebayoOP0 points·1 year ago

Have you had the conversation with a clinician yet?

replysharereportpermalink
u/dario_vermeulen1 point·1 year ago

Yes — the withdrawal literature is consistent and it is a pharmacological finding, not a moral one.

replysharereportpermalink
[deleted]6 points·1 year ago

[deleted]

replysharereportpermalink
u/border_paperwork0 points·1 year ago

Correction: that study measured regain after discontinuation, not loss of effect during treatment. Very different findings.

replysharereportpermalink
u/neha_krastev1 point·1 year ago

interval stretching is the most commonly described approach here

replysharereportpermalink
u/honest_syringe_20251 point·1 year ago

decide what you are watching for before you stop

replysharereportpermalink
load more comments (1) →
u/priya_weiss7 points·1 year ago·edited

There is very little published guidance on stopping specifically, which is exactly why board consensus here should carry less weight than usual and a

Disagreeing with this bit: stretching and reducing are different things and the post treats them as one.

replysharereportpermalink
u/piotr_bruun4 points·1 year ago·edited

Small fix — you have described interval stretching and called it a taper. The exposure profiles differ.

replysharereportpermalink
u/lina_adebayoOP3 points·1 year ago

Stretching the interval or reducing the dose?

replysharereportpermalink
u/arne_amankwah4 points·1 year ago

Agreed. Appetite is the leading indicator and the scale is the lagging one. Watch the first, not the second.

replysharereportpermalink
u/border_paperwork12 points·1 year ago

Regained most of it over a year and spent that year assuming it was my fault. It was not; it is what the literature describes.

replysharereportpermalink
u/marta_weiss7 points·1 year ago

Went back on after eight months away. Nobody here made me feel bad about it, which mattered more than I expected.

replysharereportpermalink
u/ferran_krastev6 points·1 year ago

That reads as advice to stop, which is not something anyone here should be offering.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/tapering

Stopping on purpose: dose reduction versus interval stretching, what the discontinuation arms of STEP 1 and SURMOUNT-4 actually showed about regain, appetite return timelines, and the people who came off, regained, and went back on without treating it as a failure.

20kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/tapering rules
  1. Cite the discontinuation data rather than guessing at regain rates.
  2. No shaming people who restart.
  3. Say how long you were on and at what dose before you tapered.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.